These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 23421099)

  • 1. [Drugs used to treat nicotine addiction].
    Zieleń I; Sliwińska-Mossoń M; Milnerowicz H
    Przegl Lek; 2012; 69(10):1098-102. PubMed ID: 23421099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on therapeutics for tobacco dependence.
    Lancaster T; Stead L; Cahill K
    Expert Opin Pharmacother; 2008 Jan; 9(1):15-22. PubMed ID: 18076335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of combination therapy for smoking cessation.
    Shah SD; Wilken LA; Winkler SR; Lin SJ
    J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline: for smoking cessation.
    Rao J; Shankar PK
    Kathmandu Univ Med J (KUMJ); 2009; 7(26):162-4. PubMed ID: 20071853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
    Tutka P
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1473-85. PubMed ID: 18808308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.
    Walker N; Howe C; Bullen C; McRobbie H; Glover M; Parag V; Williman J; Veale R; Nosa V; Barnes J
    BMC Public Health; 2011 Nov; 11():880. PubMed ID: 22104038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
    Giulietti F; Filipponi A; Rosettani G; Giordano P; Iacoacci C; Spannella F; Sarzani R
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):349-362. PubMed ID: 32578165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An uncontrolled trial of cytisine (Tabex) for smoking cessation.
    Zatonski W; Cedzynska M; Tutka P; West R
    Tob Control; 2006 Dec; 15(6):481-4. PubMed ID: 17130378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Past, Present, and Future of Nicotine Addiction Therapy.
    Prochaska JJ; Benowitz NL
    Annu Rev Med; 2016; 67():467-86. PubMed ID: 26332005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.